News


Published Thursday, October 13, 2011

SAN DIEGO, CA (October 13, 2011) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has submitted a Premarket Notification 510(k) application with the U.S. Food and Drug administration (FDA) for the company's ClearPath DS-120™ Lens Fluorescence Biomicroscope. more»



Published Thursday, March 10, 2011

TOLEDO, OHIO (March 10, 2011) – People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future, get the same results by rapidly shining a safe non-invasive light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science more»



Published Thursday, November 11, 2010

BETHESDA, MARYLAND (November 11, 2010) – Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between blood glucose levels and non-invasive glucose measurements in the eye in a live animal model. Results of the study more»



Published Monday, January 25, 2010

LONDON (January 25, 2010) – People with diabetes or at risk of developing the disease – now estimated at over 400 million globally - could reduce complications, improve quality of life and reduce healthcare costs by using new non-invasive technology to screen for and monitor the illness, according to a presentation by Freedom Meditech at the 6th Annual more»



Published Tuesday, October 13, 2009

PITTSBURGH, PA (October 13, 2009) – New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc. The study, involving rabbits, showed that the eye-scanning technology produced more»



Published Tuesday, August 4, 2009

CLEVELAND, OHIO & SAN DIEGO, CALIFORNIA (August 4, 2009) – Freedom Meditech, Inc., the developer of proprietary non-invasive ophthalmic medical device technologies for people with diabetes, today announced that the company closed on the second round of its Series A financing. The amount of financing was not disclosed. The financing included more»



Published Saturday, August 1, 2009

In the past, it has been challenging for developers of non-invasive glucose monitoring systems based on optical platforms to separate out the signal generated by glucose from a high level of background "noise." Freedom Meditech, which uses a beam of red light to detect the concentration of glucose in the eye, believes it overcomes this problem and expects more»



Published Tuesday, September 16, 2008

Cleveland, OH, and San Diego, CA, September 16, 2008 – JumpStart Inc., the Northeast Ohio venture development organization that accelerates the growth of innovative early-stage businesses and ideas, today announced the close of an equity investment commitment of $380,000 in Freedom Meditech, Inc., a developer of a proprietary non-invasive ocular glucose more»



Published Thursday, February 28, 2008

SAN DIEGO, CA AND COLUMBUS, OH (February 28, 2008) – Freedom Meditech, Inc., a developer of a proprietary non-invasive ocular glucose measurement technology for people with diabetes, today announced an agreement with Battelle to begin an initial phase of development for a device for use in Food and Drug Administration (FDA)-compliant pilot human clinical more»



Published Tuesday, February 12, 2008

SAN DIEGO AND CLEVELAND (February 12, 2008) – Freedom Meditech, Inc. , a San Diego­based developer of a non­invasive ocular glucose measurement technology for people with diabetes, today announced the opening of new research and development (R&D) operations in Ohio. The new R&D operation leverages a product development services agreement with more»


Items 21-30 of 32